BioPharmCatalyst is an online resource for stock market investors of publicly traded biotech and pharmaceutical companies listed on U.S. markets (NASDAQ and NYSE). A commonly used function of BioPharmCatalyst is to track pipelines of drugs in clinical development. For a drug to receive marketing approval from the Food and Drug Administration (FDA), companies must conduct human clinical trials, generally in three phases (Phase 1-3) before submitting a regulatory filing, normally a New Drug Application, to the FDA for marketing approval. However, BioPharmCatalyst provides much more than just a database to track the development of drug pipelines. Throughout this guide we will provide a deep dive into every aspect of BioPharmCatalyst - everything from your account & setup, to how BioPharmCatalyst and its various tools can be best utilized.